‌

US Patent 8962321 Mesenchymal stromal cells and uses related thereto

Patent 8962321 was granted and assigned to Ocata Therapeutics on February, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Ocata Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

February 24, 2015

Patent Application Number

13691349

Date Filed

November 30, 2012

Patent Citations Received

US Patent 12109239 Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof

0

US Patent 11680941 Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors

0

US Patent 11957754 Clinical formulations

0

US Patent 12076347 Methods for production of platelets from pluripotent stem cells and compositions thereof

0

Patent Primary Examiner

Patent abstract

The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8962321 Mesenchymal stromal cells and uses related thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.